Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 260.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 280.00 |
Description | Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |
Source |
Molecular Weight | 264.32 |
Formula | C18H16O2 |
CAS No. | 117824-04-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dehydrojuncusol 117824-04-1 Microbiology/Virology Proteases/Proteasome HCV Protease inhibitor inhibit